Terms: = Ovarian cancer AND BCL7A, BCL7, 605, ENSG00000110987
40 results:
1. Association of tet methylcytosine dioxygenase 2 and 5-hydroxymethylcytosine in endometrioid adenocarcinoma and its clinical significance.
Kuang L; Zhang J; Li Y; Wang Q; Liu J; Zhang B
BMC Womens Health; 2024 Mar; 24(1):188. PubMed ID: 38515066
[TBL] [Abstract] [Full Text] [Related]
2. Cost-effectiveness and drug wastage of bevacizumab biosimilar with or without chemotherapy for platinum-resistant recurrent ovarian cancer.
Lai SP; Wang SY; Chan AL; Leung JH; Yip HT
Expert Rev Pharmacoecon Outcomes Res; 2024 Apr; 24(4):541-549. PubMed ID: 38372034
[TBL] [Abstract] [Full Text] [Related]
3. The efficacy and toxicity of mirvetuximab soravtansine, a novel antibody-drug conjugate, in the treatment of advanced or recurrent ovarian cancer: a meta-analysis.
Xu K; Wang T; Pan S; He J
Expert Rev Clin Pharmacol; 2023; 16(11):1141-1152. PubMed ID: 37771164
[TBL] [Abstract] [Full Text] [Related]
4. O-RADS US: A Systematic Review and Meta-Analysis of Category-specific Malignancy Rates.
Lee S; Lee JE; Hwang JA; Shin H
Radiology; 2023 Aug; 308(2):e223269. PubMed ID: 37642566
[TBL] [Abstract] [Full Text] [Related]
5. OWL: an optimized and independently validated machine learning prediction model for lung cancer screening based on the UK Biobank, PLCO, and NLST populations.
Pan Z; Zhang R; Shen S; Lin Y; Zhang L; Wang X; Ye Q; Wang X; Chen J; Zhao Y; Christiani DC; Li Y; Chen F; Wei Y
EBioMedicine; 2023 Feb; 88():104443. PubMed ID: 36701900
[TBL] [Abstract] [Full Text] [Related]
6. [Effect of RBP2 gene silencing on proliferation, migration and invasion of ovarian epithelial cancer SKOV3/DDP cells and its mechanism].
Feng TF; Yao DM; Zheng R; Jiang DS; Zhang LL; Xing Q; Li L
Zhonghua Zhong Liu Za Zhi; 2022 Feb; 44(2):139-146. PubMed ID: 35184457
[No Abstract] [Full Text] [Related]
7. Completeness and accuracy of national cancer and death registration for outcome ascertainment in trials-an ovarian cancer exemplar.
Kalsi JK; Ryan A; Gentry-Maharaj A; Margolin-Crump D; Singh N; Burnell M; Benjamin E; Apostolidou S; Habib M; Massingham S; Karpinskyj C; Woolas R; Widschwendter M; Fallowfield L; Campbell S; Skates S; McGuire A; Parmar M; Jacobs I; Menon U
Trials; 2021 Jan; 22(1):88. PubMed ID: 33494753
[TBL] [Abstract] [Full Text] [Related]
8. bcl7C suppresses ovarian cancer growth by inactivating mutant p53.
Huang C; Hao Q; Shi G; Zhou X; Zhang Y
J Mol Cell Biol; 2021 May; 13(2):141-150. PubMed ID: 33306126
[TBL] [Abstract] [Full Text] [Related]
9. Biasing human epidermal growth factor receptor 4 (HER4) tyrosine kinase signaling with antibodies: Induction of cell death by antibody-dependent HER4 intracellular domain trafficking.
Lanotte R; Garambois V; Gaborit N; Larbouret C; Musnier A; Martineau P; Pèlegrin A; Chardès T
Cancer Sci; 2020 Jul; 111(7):2508-2525. PubMed ID: 32415868
[TBL] [Abstract] [Full Text] [Related]
10. Differences in Stage of cancer at Diagnosis, Treatment, and Survival by Race and Ethnicity Among Leading cancer Types.
Zhang C; Zhang C; Wang Q; Li Z; Lin J; Wang H
JAMA Netw Open; 2020 Apr; 3(4):e202950. PubMed ID: 32267515
[TBL] [Abstract] [Full Text] [Related]
11. The prophylactic effects of long-acting granulocyte colony-stimulating factor for febrile neutropenia in newly diagnosed patients with epithelial ovarian cancer: a randomised controlled study.
Li L; Ma S; Wu M; Tan X; Zhong S; Lang J
BMJ Support Palliat Care; 2019 Dec; 9(4):373-380. PubMed ID: 31467066
[TBL] [Abstract] [Full Text] [Related]
12. Final results from GCIG/ENGOT/AGO-OVAR 12, a randomised placebo-controlled phase III trial of nintedanib combined with chemotherapy for newly diagnosed advanced ovarian cancer.
Ray-Coquard I; Cibula D; Mirza MR; Reuss A; Ricci C; Colombo N; Koch H; Goffin F; González-Martin A; Ottevanger PB; Baumann K; Bjørge L; Lesoin A; Burges A; Rosenberg P; Gropp-Meier M; Harrela M; Harter P; Frenel JS; Minarik T; Pisano C; Hasenburg A; Merger M; du Bois A;
Int J Cancer; 2020 Jan; 146(2):439-448. PubMed ID: 31381147
[TBL] [Abstract] [Full Text] [Related]
13. Low bcl7a expression predicts poor prognosis in ovarian cancer.
Sun Z; Sun L; He M; Pang Y; Yang Z; Wang J
J Ovarian Res; 2019 May; 12(1):41. PubMed ID: 31077237
[TBL] [Abstract] [Full Text] [Related]
14. Goal-directed hemodynamic management in patients undergoing primary debulking gynaecological surgery: A matched-controlled precision medicine study.
Russo A; Aceto P; Grieco DL; Anzellotti GM; Perilli V; Costantini B; Romanò B; Scambia G; Sollazzi L; Antonelli M
Gynecol Oncol; 2018 Nov; 151(2):299-305. PubMed ID: 30201234
[TBL] [Abstract] [Full Text] [Related]
15. Occupational Burden of Asbestos-Related Diseases in Korea, 1998-2013: Asbestosis, Mesothelioma, Lung cancer, Laryngeal cancer, and ovarian cancer.
Kang DM; Kim JE; Kim YK; Lee HH; Kim SY
J Korean Med Sci; 2018 Aug; 33(35):e226. PubMed ID: 30140191
[TBL] [Abstract] [Full Text] [Related]
16. Exploration of the sequential gene changes in epithelial ovarian cancer induced by carboplatin via microarray analysis.
Wei S; Liu J; Shi Y; Zhang X; Yang Y; Song Q
Mol Med Rep; 2017 Sep; 16(3):3155-3160. PubMed ID: 28713952
[TBL] [Abstract] [Full Text] [Related]
17. Analysis of multiple primary cancer autopsy cases associated with breast cancer: 2002-2010.
Shibahara Y; Sugawara Y; Miki Y; Hata S; Takahashi H; Nakamura Y; Suzuki T; Ohuchi N; Tsuji I; Sasano H
Pathol Int; 2016 Dec; 66(12):695-700. PubMed ID: 27873390
[TBL] [Abstract] [Full Text] [Related]
18. High Efficacy and Low Toxicity of the Modified Docetaxel and Carboplatin Protocol in Patients with Recurrent ovarian cancer-A Phase 2 Cohort Study.
Bruchim I; Weeg N; Alpert Y; Sade D; Piura E; Fishman A
Int J Gynecol Cancer; 2016 May; 26(4):640-7. PubMed ID: 27101523
[TBL] [Abstract] [Full Text] [Related]
19. Addressing inherited predisposition for breast cancer in transplant recipients.
Yang RL; Kurian AW; Winton LM; Weill D; Patel K; Kingham K; Wapnir IL
J Surg Oncol; 2016 May; 113(6):605-8. PubMed ID: 26861253
[TBL] [Abstract] [Full Text] [Related]
20. Smoking may modify the association between neoadjuvant chemotherapy and survival from ovarian cancer.
Kelemen LE; Warren GW; Koziak JM; Köbel M; Steed H
Gynecol Oncol; 2016 Jan; 140(1):124-30. PubMed ID: 26549109
[TBL] [Abstract] [Full Text] [Related]
[Next]
